Disease research has quite a slew of information associated with it and most of it has to do with therapies. There are surgical methods correlated to brain cancer, for example, and this has a number of factors. On one hand, people can potentially be helped thanks to the method but on the other hand, there are those who may not see much in the way of progress. As stories continue to unfold, though, my faith in new therapies in the future continues to grow.
There was a clinical trial detailed on the Journal of Clinical Oncology that spoke about a trial utilizing a different kind of protocol. This was meant to benefit disease research as it would target a rare form of cancer, mostly CNS lymphoma. With enough results, this procedure could benefit the future and change the course as to how care would be utilized to help patients. It's apparent that this finding would be supported by organizations on the matter, along the lines of Voices Against Brain Cancer.
The way that this procedure worked is that there were 44 patients within the trial, each of them given a tandem of high-dose chemotherapy and immune therapy. The regular chemo procedure was not utilized and it seems like this is where the lower levels of toxicity are seen. In high doses, such a procedure can actually kill brain cells and potentially lead to the nervous system becoming deteriorated. According to the report, many patients die from such a procedure as opposed to the actual cancer.
The article talked about just how well the procedure worked. If you want specifics, you can be certain that the patients are living well and have follow-ups of five years to their names as well. If this wasn't enough, it was discovered that older patients were helped by this method as much as younger ones. This is important to note because this kind of tumor is seen more prevalently in those who are around 65 years old and the benefits clearly speak for themselves.
When it comes to disease research, you have to be able to take certain finds as they come. There are many people who will believe that this is simply a small factor that won't matter much in the long run. However, there are those who think that this is a sign and that we will be able to see finer results as the future unfolds in front of us. I find myself as part of the latter and I can only hope that, in time, more findings which will matter in the long run will be uncovered.
There was a clinical trial detailed on the Journal of Clinical Oncology that spoke about a trial utilizing a different kind of protocol. This was meant to benefit disease research as it would target a rare form of cancer, mostly CNS lymphoma. With enough results, this procedure could benefit the future and change the course as to how care would be utilized to help patients. It's apparent that this finding would be supported by organizations on the matter, along the lines of Voices Against Brain Cancer.
The way that this procedure worked is that there were 44 patients within the trial, each of them given a tandem of high-dose chemotherapy and immune therapy. The regular chemo procedure was not utilized and it seems like this is where the lower levels of toxicity are seen. In high doses, such a procedure can actually kill brain cells and potentially lead to the nervous system becoming deteriorated. According to the report, many patients die from such a procedure as opposed to the actual cancer.
The article talked about just how well the procedure worked. If you want specifics, you can be certain that the patients are living well and have follow-ups of five years to their names as well. If this wasn't enough, it was discovered that older patients were helped by this method as much as younger ones. This is important to note because this kind of tumor is seen more prevalently in those who are around 65 years old and the benefits clearly speak for themselves.
When it comes to disease research, you have to be able to take certain finds as they come. There are many people who will believe that this is simply a small factor that won't matter much in the long run. However, there are those who think that this is a sign and that we will be able to see finer results as the future unfolds in front of us. I find myself as part of the latter and I can only hope that, in time, more findings which will matter in the long run will be uncovered.
About the Author:
Visit Voices Againt Brain Cancer if you're searching for more information about cancer research.. Also published at Would Disease Research Make Use of Fewer Toxicity Instances?.
Posts
No comments:
Post a Comment